Dare Bioscience Inc. (NASDAQ:DARE) traded today at a new 52-week high of $3.85. Approximately 3.9 million shares have changed hands today, as compared to an average 30-day volume of 2.8 million shares.
In the past 52 weeks, Dare Bioscience Inc. share prices are bracketed by a low of $0.75 and a high of $3.85 and is now at $3.04, 305% above that low price.
Dare Bioscience Inc is a clinical-stage biopharmaceutical company focused on women”s reproductive health. The products of the company are related to fertility, vaginal health, and contraception. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones.
Dare Bioscience Inc. (NASDAQ:DARE) is currently priced 48.9% above its average consensus analyst price target of $1.55.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer